Combination biologic therapy for severe persistent asthma

Ann Allergy Asthma Immunol. 2019 Sep;123(3):309-311. doi: 10.1016/j.anai.2019.06.013. Epub 2019 Jun 25.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Asthma / immunology
  • Asthma / therapy*
  • Biological Therapy / methods*
  • Disease Progression
  • Drug Therapy, Combination
  • Eosinophilia
  • Female
  • Humans
  • Immunoglobulin E / immunology
  • Immunoglobulin E / metabolism
  • Interleukin-5 / antagonists & inhibitors
  • Male
  • Middle Aged
  • Omalizumab / therapeutic use
  • Severity of Illness Index

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Interleukin-5
  • Omalizumab
  • Immunoglobulin E
  • dupilumab
  • benralizumab
  • mepolizumab